open access

Vol 93, No 2 (2022)
Research paper
Published online: 2021-09-24
Get Citation

Remission of HPV infection after LEEP-conization — a retrospective study

Marcin Przybylski1, Dominik Pruski1, Sonja Millert-Kalinska12, Andrzej Zmaczynski3, Rafal Baran3, Anna Horbaczewska3, Robert Jach3, Lucja Zaborowska3
·
Pubmed: 35072214
·
Ginekol Pol 2022;93(2):99-104.
Affiliations
  1. Department of Obstetrics and Gynecology, District Public Hospital in Poznan, Poland
  2. Poznan University of Medical Science, Poland
  3. Department of Gynecological Endocrinology, Jagiellonian University Medical College, Cracow, Poland

open access

Vol 93, No 2 (2022)
ORIGINAL PAPERS Gynecology
Published online: 2021-09-24

Abstract

Objectives: Human papillomavirus (HPV) infection is one of the most common sexually transmitted diseases. Long-term exposure to the HPV is a known cause of squamous intraepithelial lesions that consequently lead to cervical cancer development. The loop electrosurgical excision procedure (LEEP) conization is an established early cervical cancer treatment method. We aim to assess the remission of HPV infection after LEEP in non-vaccinated patients with pre-cancerous cervical lesions and establish the efficacy of cervical cancer prophylaxis. Material and methods: We analyzed 31 LEEP conizations performed due to low and high-grade squamous intraepithelial lesions in 2019–2020. We obtained molecular test samples and detected DNA of 37 different HPV genotypes. After a six-month follow-up, each patient underwent subsequent high-risk HPV testing and genotyping. Results: We observed that 54.8% of qualified patients were infected with HPV 16. We discovered complete viral remission in 64.5% of cases. After surgery, margins were negative in 71% of the patient's samples. During the follow-up, six patients got infected with new strains of HPV. Conclusions: We found that a correctly performed LEEP conization may contribute to the remission of persistent HPV infection; a more extended follow-up period might be recommended due to a high rate of post-surgery HPV infections.

Abstract

Objectives: Human papillomavirus (HPV) infection is one of the most common sexually transmitted diseases. Long-term exposure to the HPV is a known cause of squamous intraepithelial lesions that consequently lead to cervical cancer development. The loop electrosurgical excision procedure (LEEP) conization is an established early cervical cancer treatment method. We aim to assess the remission of HPV infection after LEEP in non-vaccinated patients with pre-cancerous cervical lesions and establish the efficacy of cervical cancer prophylaxis. Material and methods: We analyzed 31 LEEP conizations performed due to low and high-grade squamous intraepithelial lesions in 2019–2020. We obtained molecular test samples and detected DNA of 37 different HPV genotypes. After a six-month follow-up, each patient underwent subsequent high-risk HPV testing and genotyping. Results: We observed that 54.8% of qualified patients were infected with HPV 16. We discovered complete viral remission in 64.5% of cases. After surgery, margins were negative in 71% of the patient's samples. During the follow-up, six patients got infected with new strains of HPV. Conclusions: We found that a correctly performed LEEP conization may contribute to the remission of persistent HPV infection; a more extended follow-up period might be recommended due to a high rate of post-surgery HPV infections.

Get Citation

Keywords

cervical cancer; loop electrosurgical excision procedure; LEEP; HPV

About this article
Title

Remission of HPV infection after LEEP-conization — a retrospective study

Journal

Ginekologia Polska

Issue

Vol 93, No 2 (2022)

Article type

Research paper

Pages

99-104

Published online

2021-09-24

Page views

7623

Article views/downloads

1451

DOI

10.5603/GP.a2021.0164

Pubmed

35072214

Bibliographic record

Ginekol Pol 2022;93(2):99-104.

Keywords

cervical cancer
loop electrosurgical excision procedure
LEEP
HPV

Authors

Marcin Przybylski
Dominik Pruski
Sonja Millert-Kalinska
Andrzej Zmaczynski
Rafal Baran
Anna Horbaczewska
Robert Jach
Lucja Zaborowska

References (27)
  1. WHO Cervical Cancer. https://www.who.int/health-topics/cervical-cancer (13.04.2021).
  2. Bosch FX, de Sanjosé S. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr. 2003(31): 3–13.
  3. Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4): 244–265.
  4. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000; 92(9): 690–698.
  5. Pruski D, Kędzia W, Przybylski M. The assesment of real optoelectronic method in the detection of cervical intraepithelial neoplasia. Ginekol Pol. 2008; 79(5): 342–346.
  6. Massad LS, Einstein MH, Huh WK, et al. 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013; 121(4): 829–846.
  7. Ghaem-Maghami S, Sagi S, Majeed G, et al. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. The Lancet Oncology. 2007; 8(11): 985–993.
  8. Paraskevaidis E, Arbyn M, Sotiriadis A, et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev. 2004; 30(2): 205–211.
  9. Felix JC, Muderspach LI, Duggan BD. The significance of positive margins in loop electrosurgical cone biopsies. Obstet Gynecol. 1994; 84: 996–1000.
  10. Brockmeyer AD, Wright JD, Gao F, et al. Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure. Am J Obstet Gynecol. 2005; 192(5): 1379–1381.
  11. Söderlund-Strand A, Kjellberg L, Dillner J. Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia. J Med Virol. 2014; 86(4): 634–641.
  12. Park JY, Kim DY, Kim JH, et al. Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens. Obstet Gynecol. 2009; 114(1): 87–92.
  13. Wright TC, Cox JT, Massad LS, et al. 2001 ASCCP-sponsored Consensus Workshop. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2003; 7(3): 154–167.
  14. Cricca M, Venturoli S, Morselli-Labate AM, et al. HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ. J Med Virol. 2006; 78(4): 494–500.
  15. Rositch AF, Soeters HM, Offutt-Powell TN, et al. The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review. Gynecol Oncol. 2014; 132(3): 767–779.
  16. Melnikow J, McGahan C, Sawaya GF, et al. Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst. 2009; 101(10): 721–728.
  17. Kreimer AR, Schiffman M, Herrero R, et al. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment. Int J Cancer. 2012; 131(1): 211–218.
  18. Kang WD, Oh MJ, Kim SMo, et al. Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure. Am J Obstet Gynecol. 2010; 203(1): 72.e1–72.e6.
  19. Jones J, Saleem A, Rai N, et al. Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection. J Clin Virol. 2011; 52(2): 88–92.
  20. Ribaldone R, Boldorini R, Capuano A, et al. Role of HPV testing in the follow-up of women treated for cervical dysplasia. Arch Gynecol Obstet. 2010; 282(2): 193–197.
  21. Wright TC, Massad LS, Dunton CJ, et al. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis. 2007; 11(4): 223–239.
  22. Costa S, Simone P, Venturoli S, et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecologic Oncology. 2003; 90(2): 358–365.
  23. Sarian LO, Derchain SF, Pitta Dd, et al. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol. 2004; 31(4): 270–274.
  24. Debarge V, Collinet P, Vinatier D, et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecologic Oncology. 2003; 90(3): 587–592.
  25. Alonso I, Torné A, Puig-Tintoré LM, et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol. 2006; 103(2): 631–636.
  26. Bruno MT, Cassaro N, Garofalo S, et al. HPV16 persistent infection and recurrent disease after LEEP. Virol J. 2019; 16(1): 148.
  27. Kang WD, Oh MJ, Kim SMo, et al. Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure. Am J Obstet Gynecol. 2010; 203(1): 72.e1–72.e6.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl